These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24142477)

  • 1. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease.
    Davis RL; Liang C; Edema-Hildebrand F; Riley C; Needham M; Sue CM
    Neurology; 2013 Nov; 81(21):1819-26. PubMed ID: 24142477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
    Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
    Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
    Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
    PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders.
    Suomalainen A
    Expert Opin Med Diagn; 2013 Jul; 7(4):313-7. PubMed ID: 23782039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of plasma fibroblast growth factor 23 as risk biomarker in epidemiological studies measured over a four-month period.
    di Giuseppe R; Hirche F; Montonen J; Buijsse B; Dierkes J; Stangl GI; Boeing H; Weikert C
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):542-5. PubMed ID: 23002133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.
    Viaene L; Bammens B; Meijers BK; Vanrenterghem Y; Vanderschueren D; Evenepoel P
    Nephrol Dial Transplant; 2012 May; 27(5):2017-22. PubMed ID: 22025115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
    Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
    J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
    Mikkelsen ME; Miltiades AN; Gaieski DF; Goyal M; Fuchs BD; Shah CV; Bellamy SL; Christie JD
    Crit Care Med; 2009 May; 37(5):1670-7. PubMed ID: 19325467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia).
    Salehi MH; Kamalidehghan B; Houshmand M; Aryani O; Sadeghizadeh M; Mossalaeie MM
    Mol Biol Rep; 2013 Nov; 40(11):6495-9. PubMed ID: 24078096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.
    Molema F; Jacobs EH; Onkenhout W; Schoonderwoerd GC; Langendonk JG; Williams M
    J Inherit Metab Dis; 2018 Nov; 41(6):1179-1187. PubMed ID: 30159853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
    Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
    Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system.
    Yamada K; Toribe Y; Yanagihara K; Mano T; Akagi M; Suzuki Y
    Brain Dev; 2012 Feb; 34(2):92-7. PubMed ID: 21875773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.